Pathogenetic mechanisms in endometrial stromal sarcoma

Cytogenetic and Genome Research

Volumn 118, Issue 2-4, 2007, Pages 190-195

  Micci, F ^a   Heim, S ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

WNT PROTEIN;

CARCINOGENESIS; CELL ADHESION; CELL CYCLE PROGRESSION; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; ENDOMETRIUM SARCOMA; FUSION GENE; GENE EXPRESSION; GENE REARRANGEMENT; GENOMIC INSTABILITY; HETEROZYGOSITY LOSS; HUMAN; JAZF1 GENE; MALIGNANT NEOPLASTIC DISEASE; MICROSATELLITE INSTABILITY; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; TUMOR DIFFERENTIATION; TUMOR SUPPRESSOR GENE; UTERUS TUMOR;

CHROMOSOME ABERRATIONS; ENDOMETRIAL NEOPLASMS; FEMALE; GENE REARRANGEMENT; GENES, TUMOR SUPPRESSOR; GENOMIC INSTABILITY; HUMANS; KARYOTYPING; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; SARCOMA, ENDOMETRIAL STROMAL;

EID: 36249016374     PISSN: 14248581     EISSN: None     Source Type: Journal    
DOI: 10.1159/000108300     Document Type: Review

References (59)

1. Albertson DG, Collins C, McCormick F, Gray JW: Chromosome aberrations in solid tumors. Nat Genet 34:369-376 (2003).
2. Åman P: Fusion genes in solid tumors. Semin Cancer Biol 9:303-318 (1999).
3. Amant F, Dorfling CM, Dreyer L, Vergote I, Lindeque BG, Van Rensburg EJ: Microsatellite instability in uterine sarcomas. Int J Gynecol Cancer 11:218-223 (2001).
4. Amant F, Moerman P, Cadron I, Hagemeijer A, Vergote I, Debiec-Rychter M: Endometrial stromal sarcoma with a sole t(X;17) chromosome change: report of a case and review of the literature. Gynecol Oncol 88:459-462 (2003a).
5. Amant F, Moerman P, Cadron I, Neven P, Berteloot P, Vergote I: The diagnostic problem of endometrial stromal sarcoma: report on six cases. Gynecol Oncol 90:37-43 (2003b).
6. Bennicelli JL, Barr FG: Chromosomal translocations and sarcomas. Curr Opin Oncol 14:412-419 (2002).
7. Berchuck A, Rubin SC, Hoskins WJ, Saigo PE, Pierce VK, Lewis JL Jr: Treatment of endometrial stromal tumors. Gynecol Oncol 36:60-65 (1990).
8. Chu P, Arber DA: Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma. Am J Clin Pathol 113:374-382 (2000).
9. Chu PG, Arber DA, Weiss LM, Chang KL: Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases. Mod Pathol 14:465-471 (2001).
10. Coulson M, Robert S, Eyre HJ, Saint R: The identification and localization of a human gene with sequence similarity to Polycomblike of Drosophila melanogaster. Genomics 48:381-383 (1998).
11. Dal Cin P, Talcott J, Abrams J, Li FP, Sandberg AA: Ins(10;19) in an endometrial stromal sarcoma. Cancer Genet Cytogenet 36:1-5 (1988).
12. Dal Cin P, Aly MS, De Wever I, Moerman P, Van Den Berghe H: Endometrial stromal sarcoma t(7;17)(p15-21;q12-21) is a nonrandom chromosome change. Cancer Genet Cytogenet 63:43-46 (1992).
13. Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, et al: Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 344:1031-1037 (2001).
14. Evans HL: Endometrial stromal sarcoma and poorly differentiated endometrial sarcoma. Cancer 50:2170-2182 (1982).
15. Fletcher JA, Kozakewich HP, Hoffer FA, Lage JM, Weidner N, et al: Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue tumors. N Engl J Med 324:436-442 (1991).
16. Fresia AE, Currie JL, Farrington JE, Laxman R, Griffin CA: Uterine stromal sarcoma cell line. A cytogenetic and electron microscopic study. Cancer Genet Cytogenet 60:60-66 (1992).
17. Fuzesi L, Gunawan B, Braun S, Karl MC: Endometrial stromal sarcoma with clonal chromosomal aberrations and mixed phenotype. Cancer Genet Cytogenet 84:85-88 (1995).
18. Gil-Benso R, Lopez-Gines C, Navarro S, Carda C, Llombart-Bosch A: Endometrial stromal sarcomas: immunohistochemical, electron microscopical and cytogenetic findings in two cases. Virchows Arch 434:307-314 (1999).
19. Halbwedl I, Ullmann R, Kremser ML, Man YG, Isadi-Moud N, et al: Chromosomal alterations in low-grade endometrial stromal sarcoma and undifferentiated endometrial sarcoma as detected by comparative genomic hybridization. Gynecol Oncol 97:582-587 (2005).
20. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 100:57-70 (2000).
21. Havel G, Dahlenfors R, Wedell B, Mark J: Similar chromosomal evolution in a uterine stromomyosarcoma and in one of two leiomyomas from the same patient. APMIS 97:143-146 (1989).
22. Hennig Y, Caselitz J, Bartnitzke S, Bullerdiek J: A third case of a low-grade endometrial stromal sarcoma with a t(7;17)(p14∼21;q11.2∼21). Cancer Genet Cytogenet 98:84-86 (1997).
23. Hrynchak M, Horsman D, Salski C, Berean K, Benedet JL: Complex karyotypic alterations in an endometrial stromal sarcoma. Cancer Genet Cytogenet 77:45-49 (1994).
24. Hrzenjak A, Tippl M, Kremser ML, Strohmeier B, Guelly C, et al: Inverse correlation of secreted frizzled-related protein 4 and beta-catenin expression in endometrial stromal sarcomas. J Pathol 204:19-27 (2004).
25. Hrzenjak A, Moinfar F, Tavassoli FA, Strohmeier B, Kremser ML, et al: JAZF1/JJAZ1 gene fusion in endometrial stromal sarcomas: molecular analysis by reverse transcriptase-polymerase chain reaction optimized for paraffin-embedded tissue. J Mol Diagn 7:388-395 (2005).
26. Huang HY, Ladanyi M, Soslow RA: Molecular detection of JAZF1-JJAZ1 gene fusion in endometrial stromal neoplasms with classic and variant histology: evidence for genetic heterogeneity. Am J Surg Pathol 28:224-232 (2004).
27. Iliszko M, Mandahl N, Mrozek K, Denis A, Pandis N, et al: Cytogenetics of uterine sarcomas: presentation of eight new cases and review of the literature. Gynecol Oncol 71:172-176 (1998).
28. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, et al: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818-821 (1992).
29. Kempson RL, Hendrickson MR: Smooth muscle, endometrial stromal, and mixed Mullerian tumors of the uterus. Mod Pathol 13:328-342 (2000).
30. Kennison JA: The Polycomb and trithorax group proteins of Drosophila: trans-regulators of homeotic gene function. Annu Rev Genet 29:289-303 (1995).
31. Koontz JI, Soreng AL, Nucci M, Kuo FC, Pauwels P, et al: Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors. Proc Natl Acad Sci USA 98:6348-6353 (2001).
32. Laxman R, Currie JL, Kurman RJ, Dudzinski M, Griffin CA: Cytogenetic profile of uterine sarcomas. Cancer 71:1283-1288 (1993).
33. Lengauer C: How do tumors make ends meet? Proc Natl Acad Sci USA 98:12331-12333 (2001).
34. Leunen K, Amant F, Debiec-Rychter M, Croes R, Hagemeijer A, et al: Endometrial stromal sarcoma presenting as postpartum haemorrhage: report of a case with a sole t(10;17)(q22;p13) translocation. Gynecol Oncol 91:265-271 (2003).
35. Lloreta J, Prat J: Endometrial stromal nodule with smooth and skeletal muscle components simulating stromal sarcoma. Int J Gynecol Pathol 11:293-298 (1992).
36. Major FJ, Blessing JA, Silverberg SG, Morrow CP, Creasman WT, et al: Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study. Cancer 71:1702-1709 (1993).
37. McCluggage WG, Sumathi VP, Maxwell P: CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms. Histopathology 39:273-278 (2001).
38. Micci F, Walter CU, Teixeira MR, Panagopoulos I, Bjerkehagen B, et al: Cytogenetic and molecular genetic analyses of endometrial stromal sarcoma: nonrandom involvement of chromosome arms 6p and 7p and confirmation of JAZF1/ JJAZ1 gene fusion in t(7;17). Cancer Genet Cytogenet 144:119-124 (2003).
39. Micci F, Panagopoulos I, Bjerkehagen B, Heim S: Consistent rearrangement of chromosomal band 6p21 with generation of fusion genes JAZF1/PHF1 and EPC1/PHF1 in endometrial stromal sarcoma. Cancer Res 66:107-112 (2006).
40. Moinfar F, Kremser ML, Man YG, Zatloukal K, Tavassoli FA, Denk H: Allelic imbalances in endometrial stromal neoplasms: frequent genetic alterations in the nontumorous normal-appearing endometrial and myometrial tissues. Gynecol Oncol 95:662-671 (2004).
41. Nakajima T, Fujino S, Nakanishi G, Kim YS, Jetten AM: TIP27: a novel repressor of the nuclear orphan receptor TAK1/TR4. Nucleic Acids Res 32:4194-4204 (2004).
42. Norris HJ, Taylor HB: Mesenchymal tumors of the uterus. I. A clinical and pathological study of 53 endometrial stromal tumors. Cancer 19:755-766 (1966).
43. Nowell PC: The clonal evolution of tumor cell populations. Science 194:23-28 (1976).
44. Nucci MR, O'Connell JT, Huettner PC, Cviko A, Sun D, Quade BJ: h-Caldesmon expression effectively distinguishes endometrial stromal tumors from uterine smooth muscle tumors. Am J Surg Pathol 25:455-463 (2001).
45. Oliva E, Young RH, Clement PB, Bhan AK, Scully RE: Cellular benign mesenchymal tumors of the uterus. A comparative morphologic and immunohistochemical analysis of 33 highly cellular leiomyomas and six endometrial stromal nodules, two frequently confused tumors. Am J Surg Pathol 19:757-768 (1995).
46. Oliva E, Clement PB, Young RH: Endometrial stromal tumors: an update on a group of tumors with a protean phenotype. Adv Anat Pathol 7:257-281 (2000).
47. Pauwels P, Dal Cin P, Van de Moosdijk CN, Vrints L, Sciot R, Van Den Berghe H: Cytogenetics revealing the diagnosis in a metastatic endometrial stromal sarcoma. Histopathology 29:84-87 (1996).
48. Rabbitts TH: Chromosomal translocations in human cancer. Nature 372:143-149 (1994).
49. Ried T, Heselmeyer-Haddad K, Blegen H, Schrock E, Auer G: Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: a phenotype/genotype correlation. Genes Chromosomes Cancer 25:195-204 (1999).
50. Rowley JD: Chromosome translocations: dangerous liaisons revisited. Nat Rev Cancer 1:245-250 (2001).
51. Rush DS, Tan J, Baergen RN, Soslow RA: h-Caldesmon, a novel smooth muscle-specific antibody, distinguishes between cellular leiomyoma and endometrial stromal sarcoma. Am J Surg Pathol 25:253-258 (2001).
52. Satoh Y, Ishikawa Y, Miyoshi T, Mukai H, Okumura S, Nakagawa K: Pulmonary metastases from a low-grade endometrial stromal sarcoma confirmed by chromosome aberration and fluorescence in-situ hybridization approaches: a case of recurrence 13 years after hysterectomy. Virchows Arch 442:173-178 (2003).
53. Scully RE, Bonfiglio TA, Kurman RJ, Silverberg SG, Wilkinson E: Uterine corpus: World Health Organization: Histological Typing of Female Genital Tract Tumors, pp 13-31 (Springer-Verlag, New York 1994).
54. Simon J: Locking in stable states of gene expression: transcriptional control during Drosophila development. Curr Opin Cell Biol 7:376-385 (1995).
55. Sonobe H, Iwata J, Furihata M, Ohtsuki Y, Taguchi T, Shimizu K: Endometrial stromal sarcoma with clonal complex chromosome abnormalities. Report of a case and review of the literature. Cancer Genet Cytogenet 112:34-37 (1999).
56. Sreekantaiah C, Li FP, Weidner N, Sandberg AA: An endometrial stromal sarcoma with clonal cytogenetic abnormalities. Cancer Genet Cytogenet 55:163-166 (1991).
57. Taki T, Taniwaki M: Chromosomal translocations in cancer and their relevance for therapy. Curr Opin Oncol 18:62-68 (2006).
58. Tavassoli FA, Devilee P: World Health Organization classification of tumors: Pathology and genetics of tumors of the breast and female genital organs. (IARC Press, Lyon 2003).
59. Tomlinson IP, Lambros MB, Roylance RR: Loss of heterozygosity analysis: practically and conceptually flawed? Genes Chromosomes Cancer 34:349-353 (2002).